Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Generation Bio (GBIO) Share-based Compensation (2021 - 2025)

Historic Share-based Compensation for Generation Bio (GBIO) over the last 5 years, with Q3 2025 value amounting to $2.0 million.

  • Generation Bio's Share-based Compensation fell 4730.81% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 million, marking a year-over-year decrease of 4947.13%. This contributed to the annual value of $14.6 million for FY2024, which is 3998.19% down from last year.
  • According to the latest figures from Q3 2025, Generation Bio's Share-based Compensation is $2.0 million, which was down 4730.81% from $1.7 million recorded in Q2 2025.
  • Generation Bio's Share-based Compensation's 5-year high stood at $6.7 million during Q2 2022, with a 5-year trough of $1.7 million in Q2 2025.
  • Over the past 5 years, Generation Bio's median Share-based Compensation value was $5.0 million (recorded in 2021), while the average stood at $4.6 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first surged by 7436.04% in 2022, then crashed by 5420.61% in 2025.
  • Quarter analysis of 5 years shows Generation Bio's Share-based Compensation stood at $5.0 million in 2021, then increased by 16.22% to $5.8 million in 2022, then grew by 3.44% to $6.0 million in 2023, then crashed by 47.75% to $3.2 million in 2024, then crashed by 37.44% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $1.7 million for Q2 2025, and $2.0 million during Q1 2025.